Larazotide
Also known as: Larazotide acetate · AT-1001 · zonulin antagonist
A synthetic octapeptide studied for tightening intestinal barrier junctions ("leaky gut") and gut-related immune research.
Larazotide (larazotide acetate) is a synthetic peptide studied for its effect on the tight junctions between intestinal cells. By acting as a zonulin antagonist it is researched for reducing intestinal permeability — the "leaky gut" concept.
This places it in the gut-health research category alongside BPC-157 and KPV, though it works by a distinct mechanism: tightening the barrier rather than protecting or calming the tissue.
Handled strictly for research purposes only.
ON THIS SITE
RELATED TERMS
BPC-157
A 15-amino-acid peptide derived from a gastric protein, studied for tendon, ligament, gut and soft-tissue repair.
KPV
A tripeptide (lysine-proline-valine) from the C-terminus of alpha-MSH, studied for anti-inflammatory and gut-calming effects.
Cytoprotection
Protection of cells against injury — a proposed mechanism for gut- and tissue-protective research peptides.
Inflammation / Anti-inflammatory
The body’s protective response to injury; calming excess inflammation is a target of gut- and repair-peptide research.
Educational content, not medical advice. All products supplied for research purposes only — not for human consumption.